Skip to main content
logo
BriaCell Therapeutics Corp. (TSX:BCT)
Canada flag Canada · Delayed Price · Currency is CAD
4.810
-0.070 (-1.43%)
Oct 19, 2026, 2:03 PM EST

BriaCell Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Market Capitalization
42181914013098
Market Cap Growth
34.62%-5.88%-86.55%7.66%32.65%1321.84%
Enterprise Value
10-0171027373
Last Close Price
4.8810.10154.501314.001257.00963.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
PB Ratio
1.330.74-5.08-28.189.822.84
P/TBV Ratio
1.310.72--10.052.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Debt / Equity Ratio
-----0.00
Net Debt / Equity Ratio
-0.97-1.030.325.63-3.97-2.07
Net Debt / EBITDA Ratio
0.720.660.030.912.698.22
Net Debt / FCF Ratio
0.740.630.040.903.297.39
Quick Ratio
6.354.490.2111.8043.64102.88
Current Ratio
7.075.010.4914.9645.00103.81
Return on Equity (ROE)
-175.25%-362.56%--619.75%-141.25%-114.78%
Return on Assets (ROA)
-90.84%-123.56%-126.11%-41.71%-18.99%-14.89%
Return on Capital Employed (ROCE)
-136.40%-153.90%2097.70%-91.80%-36.70%-12.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Earnings Yield
-98.35%-205.42%-35.14%-19.08%-26.45%-17.58%
FCF Yield
-99.24%-219.93%-180.31%-22.31%-12.30%-9.86%
Buyback Yield / Dilution
-1260.31%-285.70%-5.35%-0.81%-242.82%-